SHAREHOLDERS EQUITY |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SHAREHOLDERS EQUITY | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SHAREHOLDERS' EQUITY |
7. SHAREHOLDERS’ EQUITY
Shares Outstanding
The table below details the change in Company shares outstanding by class during the nine months ended September 30, 2024:
The Super Voting Shares carry 1,000 votes per share. The Subordinate Voting Shares carry 1 vote per share.
Warrants
A reconciliation of the beginning and ending balances of warrants outstanding is as follows:
At September 30, 2024, on a weighted average basis, warrants outstanding have an exercise price of $20.15 and expire by December, 2026. Warrants convert into subordinate voting shares. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|